Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
688336
주식 순위
#3772
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
주가
$4.87
시가총액
$4.36B
변동 (1일)
-5.47%
변동 (1년)
-15.62%
국가
CN
거래 Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
카테고리
Healthcare
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)의 배당 이력
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (주식 심볼: 688336)은 총 5회의 배당금을 지급했습니다.
모든 배당금의 합계 (주식 분할 반영): $0.63
배당 수익률 (TTM): 0.0149
모든 배당금의 합계 (주식 분할 반영): $0.63
배당 수익률 (TTM): 0.0149
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)의 2024부터 2026까지 배당 지급 내역
연간 배당 지급
| 연도 | 배당금 (주식 분할 조정됨) | 변화 |
|---|---|---|
| 2026 (TTM) | $0.45 | 265.85% |
| 2025 | $0.123 | 114.66% |
| 2024 | $0.0573 | 0.00% |
모든 배당 지급 목록
| 연도 | 배당금 | 변화 |
|---|---|---|
| 2026 (TTM) | $0.6525 | 265.75% |
| 2025 | $0.1784 | 114.94% |
| 2024 | $0.083 | 0.00% |
유사 기업 또는 경쟁사의 배당 지급
| 회사 | 배당 지급 횟수 | 국가 |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 67.00% |
AU
|
|
| 30.00% |
BE
|
|
| 0.00% |
NL
|
